Aluminum Granuloma After Administration of the Quadrivalent Human Papillomavirus Vaccine. Report of a Case

被引:27
作者
Marsee, Derek K. [1 ]
Williams, John M. [2 ]
Velazquez, Elsa F. [1 ]
机构
[1] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA
关键词
vaccine; granuloma; HPV; aluminum;
D O I
10.1097/DAD.0b013e318185a691
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
We report the case of a young woman who developed a subcutaneous granulomatous response after administration of the quadrivalent human papillomavirus vaccine. The inciting agent was most likely an aluminum adjuvant, which previously has been reported to be associated with a granulomatous response after administration of other vaccines. Histologically, the lesion consisted of a necrotic/necrobiotic center surrounded by palisading epithelioid histiocytes closely resembling deep granuloma annulare or rheumatoid nodule. The histiocytes contained abundant intracytoplasmic violaceous/gray granular material. An ammonium aurintricarboxylate (Aluminon) stain demonstrated the presence of aluminum in the granular material. Aluminum granulomas should be included in the differential diagnosis of deep granulomatous reaction in young women, due to the high frequency of vaccination in this population.
引用
收藏
页码:622 / 624
页数:3
相关论文
共 12 条
[1]   Persistent nodules at injection sites (aluminium granuloma) - clinicopathological study of 14 cases with a diverse range of histological reaction patterns [J].
Chong, H ;
Brady, K ;
Metze, D ;
Calonje, E .
HISTOPATHOLOGY, 2006, 48 (02) :182-188
[2]   What are the limits of adjuvanticity? [J].
Del Giudice, G ;
Podda, A ;
Rappuoli, R .
VACCINE, 2001, 20 :S38-S41
[3]   ALUMINUM TATTOO - A PHENOMENON THAT CAN RESEMBLE PARASITIZED HISTIOCYTES [J].
ELSTON, DM ;
BERGFELD, WF ;
MCMAHON, JT .
JOURNAL OF CUTANEOUS PATHOLOGY, 1993, 20 (04) :326-329
[4]  
Fairweather Peta, 2005, Australas J Dermatol, V46, P124, DOI 10.1111/j.1440-0960.2005.00158.x
[5]   PERSISTENT SUBCUTANEOUS NODULES IN PATIENTS HYPOSENSITIZED WITH ALUMINUM-CONTAINING ALLERGEN EXTRACTS [J].
GARCIAPATOS, V ;
PUJOL, RM ;
ALOMAR, A ;
CISTERO, A ;
CURELL, R ;
FERNANDEZFIGUERAS, M ;
DEMORAGAS, JM .
ARCHIVES OF DERMATOLOGY, 1995, 131 (12) :1421-1424
[6]   Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle [J].
Gherardi, RK ;
Coquet, M ;
Cherin, P ;
Belec, L ;
Moretto, P ;
Dreyfus, PA ;
Pellissier, JF ;
Chariot, P ;
Authier, FJ .
BRAIN, 2001, 124 :1821-1831
[7]   Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine [J].
Harro, CD ;
Pang, YYS ;
Roden, RBS ;
Hildesheim, A ;
Wang, ZH ;
Reynolds, MJ ;
Mast, TC ;
Robinson, R ;
Murphy, BR ;
Karron, RA ;
Dillner, J ;
Schiller, JT ;
Lowy, DR .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (04) :284-292
[8]  
Markowitz Lauri E., 2007, Morbidity and Mortality Weekly Report, V56, P1
[9]   ALUMINUM-INDUCED GRANULOMAS IN A TATTOO [J].
MCFADDEN, N ;
LYBERG, T ;
HENSTENPETTERSEN, A .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1989, 20 (05) :903-908
[10]   POSTIMMUNIZATION (VACCINATION) INJECTION-SITE REACTIONS - A REPORT OF 4 CASES AND REVIEW OF THE LITERATURE [J].
MILIAUSKAS, JR ;
MUKHERJEE, T ;
DIXON, B .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1993, 17 (05) :516-524